About the author

Bernard Munos

Bernard Munos is an advisor in corporate strategy at Eli Lilly and Company. His research interests center on disruptive innovation and the radical redesign of the pharmaceutical business model. He received his MBA from Stanford University, and holds other degrees in economics and animal science from the University of California at Davis, and the Institut National Agronomique in Paris, France.